[Code of Federal Regulations] [Title 42, Volume 3] [Revised as of October 1, 2007] From the U.S. Government Printing Office via GPO Access [CITE: 42CFR423.329] [Page 415-416] TITLE 42--PUBLIC HEALTH HUMAN SERVICES PART 423_VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT--Table of Contents Subpart G_Payments to Part D Plan Sponsors For Qualified Prescription Drug Coverage Sec. 423.329 Determination of payments. (a) Subsidy payments--(1) Direct subsidy. CMS makes a direct subsidy payment for each Part D eligible beneficiary enrolled in a Part D plan for a month equal to the amount of the plan's approved standardized bid, adjusted for health status (as determined under Sec. 423.329(b)(1)), and reduced by the base beneficiary premium for the plan (as determined under Sec. 423.286(c) and adjusted in Sec. 423.286(d)(1)). The direct subsidy payment may be increased by the excess amount of a negative premium as described in Sec. 423.286(d)(1), if applicable. (2) Subsidy through reinsurance. CMS makes reinsurance subsidy payments as provided under paragraph (c) of this section. (3) Low-income cost-sharing subsidy. CMS makes low-income cost- sharing subsidy payments as provided under paragraph (d) of this section. (b) Health status risk adjustment--(1) Establishment of risk factors. CMS establishes an appropriate methodology for adjusting the standardized bid amount to take into account variation in costs for basic prescription drug coverage among Part D plans based on the differences in actuarial risk of different enrollees being served. Any risk adjustment is designed in a manner so as to be budget neutral in the aggregate to the risk of the Part D eligible individuals who enroll in Part D plans. (2) Considerations. In establishing the methodology under paragraph (b)(1) of this section, CMS takes into account the similar methodologies used under Sec. 422.308(c) of this chapter to adjust payments to MA organizations for benefits under the original Medicare fee-for-service program option. (3) Data collection. In order to carry out this paragraph, CMS requires-- (i) PDP sponsors to submit data regarding drug claims that can be linked at the individual level to Part A and Part B data in a form and manner similar to the process provided under Sec. 422.310 of this chapter and other information as CMS determines necessary; and (ii) MA organizations that offer MA-PD plans to submit data regarding drug claims that can be linked at the individual level to other data that the organizations are required to submit to CMS in a form and manner similar to the process provided under Sec. 422.310 of this chapter and other information as CMS determines necessary. (4) Publication. At the time of publication of risk adjustment factors under Sec. 422.312(a)(1)(ii) of this chapter, CMS publishes the risk adjusters established under this paragraph of this section for the upcoming calendar year. (c) Reinsurance payment amount--(1) General rule. The reinsurance payment amount for a Part D eligible individual enrolled in a Part D plan for a coverage year is an amount equal to 80 percent of the allowable reinsurance costs attributable to that portion of gross covered prescription drug costs incurred in the coverage year after the individual has incurred true out-of-pocket costs that exceed the annual out-of-pocket threshold specified in Sec. 423.104(d)(5)(iii). [[Page 416]] (2) Payment method. Payments under this section are based on a method that CMS determines. (i) Payments during the coverage year. CMS establishes a payment method by which payments of amounts under this section are made on a monthly basis during a year based on either estimated or incurred allowable reinsurance costs. (ii) Final payments. CMS reconciles the payments made during the coverage year to final actual allowable reinsurance costs as provided in Sec. 423.343(c). (3) Special rules for private fee-for-service Plans offering prescription drug coverage. CMS determines the amount of reinsurance payments for private fee-for-service plans as defined by Sec. 422.4(a)(3) of this chapter offering qualified prescription drug coverage using a methodology that-- (i) Bases the amount on CMS' estimate of the amount of the payments that are payable if the plan were an MA-PD plan described in section 1851(a)(2)(A)(i) of the Act; and (ii) Takes into account the average reinsurance payments made under Sec. 423.329(c) for populations of similar risk under MA-PD plans described in section 1851(a)(2)(A)(i) of the Act. (d) Low-income cost sharing subsidy payment amount--(1) General rule. The low-income cost-sharing subsidy payment amount on behalf of a low-income subsidy eligible individual enrolled in a Part D plan for a coverage year is the amount described in Sec. 423.782. (2) Payment method. Payments under this section are based on a method that CMS determines. (i) Interim payments. CMS establishes a payment method by which interim payments of amounts under this section are made during a year based on the low-income cost-sharing assumptions submitted with plan bids under Sec. 423.265(d)(2)(iv) and negotiated and approved under Sec. 423.272. (ii) Final payments. CMS reconciles the interim payments to actual incurred low-income cost-sharing costs as provided in Sec. 423.343(d).